Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Rheumatology Reports
Published in: Current Rheumatology Reports 8/2016

Open Access 01-08-2016 | Health Economics and Quality of Life (M Harrison, Section Editor)

Economic Theory and Self-Reported Measures of Presenteeism in Musculoskeletal Disease

Authors: Cheryl Jones, Katherine Payne, Brenda Gannon, Suzanne Verstappen

Published in: Current Rheumatology Reports | Issue 8/2016

Login to get access

Abstract

This study had two objectives: to describe the historical development of self-reported presenteeism instruments that can be used to identify and measure presenteeism as a result of musculoskeletal disease (MSD) and to identify if, and how many of these, presenteeism instruments are underpinned by economic theory. Systematic search methods were applied to identify self-report instruments used to quantify presenteeism caused by MSD. A total of 24 self-reported presenteeism instruments were identified; 24 were designed for use in general health, and 1 was specifically designed for use in rheumatoid arthritis. One generic self-reported presenteeism instrument was explicitly reported to be underpinned by economic theory. Overtime, self-reported presenteeism instruments have become more differentiated and complex by incorporating many different contextual factors that may impact levels of presenteeism. Researchers are encouraged to further develop presenteeism instruments that are underpinned by relevant economic theory and informed by robust empirical research.
Appendix
Available only for authorised users
Literature
1.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.CrossRefPubMed
2.
Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229.CrossRefPubMedPubMedCentral
3.
Burton W, Morrison A, MacLean R, Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond). 2006;56(1):18–27.CrossRef
4.
Verstappen SM, Bijlsma JW, Verkleij H, Buskens E, Blaauw AA, ter Borg EJ, et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004;51(3):488–97.CrossRefPubMed
5.
Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S. Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis. 2001;60(4):353–8.CrossRefPubMedPubMedCentral
6.
Verstappen SM. Rheumatoid arthritis and work: the impact of rheumatoid arthritis on absenteeism and presenteeism. Best Pract Res Clin Rheumatol. 2015;29(3):495–511.CrossRefPubMed
7.
ter Wee MM, Lems WF, Usan H, Gulpen A, Boonen A. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Ann Rheum Dis. 2012;71(2):161–71.CrossRefPubMed
8.
Tillett W, de-Vries C, McHugh NJ. Work disability in psoriatic arthritis: a systematic review. Rheumatology (Oxford). 2012;51(2):275–83.CrossRef
9.
Sloman J, Wride A, Garrat D. “Introducing Economics” in Economics. 8th ed. Harlow, New York: Pearson; 2012.
10.
Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics. 2004;22(4):225–44.CrossRefPubMed
11.
Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am J Manag Care. 2007;13(4):211–7.PubMed
12.
Zhang W, Bansback N, Anis AH. Measuring and valuing productivity loss due to poor health: a critical review. Soc Sci Med. 2011;72(2):185–92.CrossRefPubMed
13.
Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014;32(4):335–44.CrossRefPubMed
14.
Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, Strand V, et al. Worker productivity outcome measures in arthritis. J Rheumatol. 2007;34(6):1372–80.PubMed
15.
Brooks A, Hagen SE, Sathyanarayanan S, Schultz AB, Edington DW. Presenteeism: critical issues. J Occup Environ Med. 2010;52(11):1055–67.CrossRefPubMed
16.
Verstappen SM, Fautrel B, Dadoun S, Symmons DP, Boonen A. Methodological issues when measuring paid productivity loss in patients with arthritis using biologic therapies: an overview of the literature. Rheumatology (Oxford). 2012;51(2):216–29.CrossRef
17.
Koopmanschap MA, van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Soc Sci Med. 1992;34(9):1005–10.CrossRefPubMed
18.
Lensberg BR, Drummond MF, Danchenko N, Despiegel N, Francois C. Challenges in measuring and valuing productivity costs, and their relevance in mood disorders. Clinicoecon Outcome Res. 2013;5:565–73.CrossRef
19.
Pauly MV, Nicholson S, Polsky D, Berger ML, Sharda C. Valuing reductions in on-the-job illness: ‘presenteeism’ from managerial and economic perspectives. Health Econ. 2008;17(4):469–85.CrossRefPubMed
20.
CRD. Systematic Reviews: CRD’s guidance for undertaking reviews in health care. Third ed. University of York; 2009.
21.•
Ospina MB, Dennett L, Waye A, Jacobs P, Thompson AH. A systematic review of measurement properties of instruments assessing presenteeism. Am J Manag Care. 2015;21(2):e171–85. This review focuses on identifying all measures of presenteeism, general or disease-specific, and evaluates the psychometric properties of each presenteeism instrument.PubMed
22.
Osterhaus JT, Purcaru O, Richard L. Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA). Arthritis Res Ther. 2009;11(3):R73.CrossRefPubMedPubMedCentral
23.
Jette AM, Davies AR, Cleary PD, Calkins DR, Rubenstein LV, Fink A, et al. The functional status questionnaire: reliability and validity when used in primary care. J Gen Intern Med. 1986;1(3):143–9.CrossRefPubMed
24.
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–65.CrossRefPubMed
25.
van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care. 1996;12(3):405–15.CrossRefPubMed
26.
Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull. 1997;33(1):13–6.PubMed
27.
Kopec JA, Esdaile JM. Occupational role performance in persons with back pain. Disabil Rehabil. 1998;20(10):373–9.CrossRefPubMed
28.
Brouwer WB, Koopmanschap MA, Rutten FF. Productivity losses without absence: measurement validation and empirical evidence. Health Policy. 1999;48(1):13–27.CrossRefPubMed
29.
Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The role of health risk factors and disease on worker productivity. J Occup Environ Med. 1999;41(10):863–77.CrossRefPubMed
30.
Amick III BC, Lerner D, Rogers WH, Rooney T, Katz JN. A review of health-related work outcome measures and their uses, and recommended measures. Spine (Phila Pa 1976). 2000;25(24):3152–60.CrossRef
31.
Lerner D, Amick III BC, Rogers WH, Malspeis S, Bungay K, Cynn D. The work limitations questionnaire. Med Care. 2001;39(1):72–85.CrossRefPubMed
32.
Pelletier KR, Koopman C. Standford/American health association presenteeism scale (SAHAPS). In: Lynch W, Riedel J, editors. Measuring employee productivity: a guide to self-assessment tools. Scottsdale, AZ: Institute for Health and Productivity Management 67; 2001.
33.
Koopman C, Pelletier KR, Murray JF, Sharda CE, Berger ML, Turpin RS, et al. Stanford presenteeism scale: health status and employee productivity. J Occup Environ Med. 2002;44(1):14–20.CrossRefPubMed
34.
Gilworth G, Chamberlain MA, Harvey A, Woodhouse A, Smith J, Smyth MG, et al. Development of a work instability scale for rheumatoid arthritis. Arthritis Rheum. 2003;49(3):349–54.CrossRefPubMed
35.
Goetzel RZ, Ozminkowski RJ, Long SR. Development and reliability analysis of the Work Productivity Short Inventory (WPSI) instrument measuring employee health and productivity. J Occup Environ Med. 2003;45(7):743–62.CrossRefPubMed
36.
Kessler RC, Barber C, Beck A, Berglund P, Cleary PD, McKenas D, et al. The world health organization health and work performance questionnaire (HPQ). J Occup Environ Med. 2003;45(2):156–74.CrossRefPubMed
37.
Kumar RN, Hass SL, Li JZ, Nickens DJ, Daenzer CL, Wathen LK. Validation of the Health-Related Productivity Questionnaire Diary (HRPQ-D) on a sample of patients with infectious mononucleosis: results from a phase 1 multicenter clinical trial. J Occup Environ Med. 2003;45(8):899–907.CrossRefPubMed
38.
Shikiar R, Halpern MT, Rentz AM, Khan ZM. Development of the Health and Work Questionnaire (HWQ): an instrument for assessing workplace productivity in relation to worker health. Work. 2004;22(3):219–29.PubMed
39.
Stewart WF, Ricci JA, Leotta C, Chee E. Validation of the work and health interview. Pharmacoeconomics. 2004;22(17):1127–40.CrossRefPubMed
40.
Turpin RS, Ozminkowski RJ, Sharda CE, Collins JJ, Berger ML, Billotti GM, et al. Reliability and validity of the Stanford Presenteeism Scale. J Occup Environ Med. 2004;46(11):1123–33.CrossRefPubMed
41.
Ilmarinen J. The Work Ability Index (WAI). J Occup Environ Med Am Coll Occup Environ Med. 2007;57(2):160.
42.
Prochaska JO, Evers KE, Johnson JL, Castle PH, Prochaska JM, Sears LE, et al. The well-being assessment for productivity: a well-being approach to presenteeism. J Occup Environ Med. 2011;53(7):735–42.CrossRefPubMed
43.•
Zhang W, Bansback N, Boonen A, Severens JL, Anis AH. Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis. Value Health. 2012;15(1):46–54. This study describes the development of the valuation of lost productivity (VOLP) questionnaire. It is the only identified presenteeism instrument that explicitly discussed the economic theory of productivity and how it was used to inform the design of the VOLP.CrossRefPubMed
44.
Boezeman EJ, Sluiter JK, Nieuwenhuijsen K. Measuring work functioning: validity of a weighted composite work functioning approach. J Occup Rehabil. 2015;25(3):537–42.CrossRefPubMed
45.
Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van RL. The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18(6):753–8.CrossRefPubMed
46.
Koopmanschap MA. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev Pharmacoecon Outcome Res. 2005;5(1):23–8.CrossRef
47.
Noben CY, Evers SM, Nijhuis FJ, de Rijk AE. Quality appraisal of generic self-reported instruments measuring health-related productivity changes: a systematic review. BMC Public Health. 2014;14:115.CrossRefPubMedPubMedCentral
48.
Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, et al. Worker productivity outcome measures: OMERACT filter evidence and agenda for future research. J Rheumatol. 2014;41(1):165–76.CrossRefPubMed
Metadata
Title
Economic Theory and Self-Reported Measures of Presenteeism in Musculoskeletal Disease
Authors
Cheryl Jones
Katherine Payne
Brenda Gannon
Suzanne Verstappen
Publication date
01-08-2016
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 8/2016
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-016-0600-1

Other articles of this Issue 8/2016

Current Rheumatology Reports 8/2016 Go to the issue

Biosimilars (E Mysler, Section Editor)

Pharmacoeconomics of Biosimilars: What Is There to Gain from Them?

Osteoarthritis (MB Goldring, Section Editor)

Histone Deacetylases in Cartilage Homeostasis and Osteoarthritis

Health Economics and Quality of Life (M Harrison, Section Editor)

Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences

Vasculitis (LR Espinoza, Section Editor)

Neuromyelitis Optica (Devic’s Syndrome): an Appraisal

Scleroderma (J Varga, Section Editor)

Erectile Dysfunction in Systemic Sclerosis

Osteoarthritis (MB Goldring, Section Editor)

The Role of MicroRNAs and Their Targets in Osteoarthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits